Sangamo receives $13m upfront in Shire haemophilia deal
02 February 2012
Pial Ganguli
Please Login to read the full article.
02 February 2012
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Aveo licences preclinical RON-targeted antibodies to J&J, for $15 million up front
- GSK taps Angiochem to take enzymes across blood-brain barrier
- Novartis expands HCV plans with Enanta collaboration; $34M upfront in $406M deal
- Xoma to use acquired Servier hypertension drug to establish a US commercial operation
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
